4167
松瑞藥
+0.05 (+0.26%)19.10418成交張數5.74本益比1.35股價淨值比7.79%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入20251,202年增 -1.3%
毛利率202535.2%最新一期
營業利益率202515.2%最新一期
每股盈餘20251.72年增 +201.8%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 87.8% | 72.8% | 106.4% | 73.4% | 69.4% | 82.3% | 89.7% | 79.0% | 71.5% | 64.8% | |
| 營業毛利（毛損） | 12.2% | 27.2% | -6.4% | 26.6% | 30.6% | 17.7% | 10.3% | 21.0% | 28.5% | 35.2% | |
| 營業毛利（毛損）淨額 | 12.2% | 27.2% | -6.4% | 26.6% | 30.6% | 17.7% | 10.3% | 21.0% | 28.5% | 35.2% | |
| 推銷費用 | 4.0% | 3.2% | 6.4% | 2.1% | 2.2% | 2.0% | 2.4% | 3.6% | 3.9% | 5.4% | |
| 管理費用 | 4.3% | 4.2% | 6.7% | 5.5% | 5.3% | 4.6% | 6.0% | 7.2% | 8.7% | 7.7% | |
| 研究發展費用 | 15.8% | 13.3% | 12.9% | 14.2% | 9.8% | 9.6% | 9.4% | 10.6% | 6.2% | 5.6% | |
| 預期信用減損損失（利益） | – | – | -0.7% | 0.5% | 0.7% | -0.2% | 0.0% | -0.2% | 0.0% | 1.3% | |
| 營業費用合計 | 24.1% | 20.8% | 25.3% | 22.4% | 18.0% | 16.0% | 17.8% | 21.3% | 18.7% | 20.1% | |
| 營業利益（損失） | -11.9% | 6.6% | -31.6% | 4.2% | 12.6% | 1.7% | -7.4% | -0.2% | 9.8% | 15.2% | |
| 利息收入 | – | – | – | – | 0.1% | 0.0% | 1.3% | 4.2% | 3.6% | 3.7% | |
| 其他收入 | 0.3% | 0.6% | 0.4% | 0.3% | 3.7% | 0.4% | 0.4% | 0.4% | 1.1% | 0.9% | |
| 其他利益及損失淨額 | 0.5% | -4.2% | 0.3% | -2.4% | -1.4% | -0.5% | 9.9% | -0.8% | 0.9% | 25.2% | |
| 財務成本淨額 | 2.3% | 1.7% | 1.6% | 2.4% | 1.3% | 1.0% | 1.2% | 0.9% | 0.6% | 0.5% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | – | – | – | – | – | – | -0.0% | -0.0% | 0.0% | |
| 營業外收入及支出合計 | -1.6% | -5.2% | -0.9% | -4.6% | 1.1% | -1.1% | 10.3% | 2.9% | 5.0% | 29.3% | |
| 稅前淨利（淨損） | -13.6% | 1.4% | -32.5% | -0.4% | 13.7% | 0.6% | 2.9% | 2.6% | 14.7% | 44.4% | |
| 所得稅費用（利益）合計 | – | – | – | – | – | – | 0.0% | 0.0% | 0.1% | 0.0% | |
| 繼續營業單位本期淨利（淨損） | -13.6% | 1.4% | -32.5% | -0.4% | 13.7% | 0.6% | 2.9% | 2.6% | 14.7% | 44.4% | |
| 本期淨利（淨損） | -13.6% | 1.4% | -32.5% | -0.4% | 13.7% | 0.6% | 2.9% | 2.6% | 14.7% | 44.4% | |
| 本期綜合損益總額 | -13.6% | 1.4% | -32.5% | -0.4% | 13.7% | 0.6% | 2.9% | 2.6% | 14.7% | 44.4% | |
| 母公司業主（淨利∕損） | – | – | – | – | – | – | 2.9% | 2.9% | 15.0% | 44.7% | |
| 非控制權益（淨利∕損） | – | – | – | – | – | – | -0.0% | -0.2% | -0.3% | -0.3% | |
| 母公司業主（綜合損益） | – | – | – | – | – | – | 2.9% | 2.9% | 15.0% | 44.7% | |
| 非控制權益（綜合損益） | – | – | – | – | – | – | -0.0% | -0.2% | -0.3% | -0.3% | |
| 基本每股盈餘 | -0.1% | 0.0% | -0.1% | -0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | |
| 稀釋每股盈餘 | – | 0.0% | -0.1% | -0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | |
| 繼續營業單位淨利（淨損） | -0.0% | 0.0% | -0.0% | -0.0% | 0.0% | 0.0% | 0.0% | – | – | – | |
| 確定福利計畫之再衡量數 | -0.0% | -0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 其他綜合損益（淨額） | -0.0% | -0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 其他收益及費損淨額 | – | 0.1% | 0.0% | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。